Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10248)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
PAQR3
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Nuclear factor erythroid 2-related factor 2 (NFE2L2) [Suppressor; Marker]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Target for Ferroptosis | Marker/Suppressor | |||
| Responsed Disease | Myeloid leukaemia | ICD-11: 2B33 | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Ubiquitin mediated proteolysis | hsa04120 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
In Vitro Model |
MOLT-3 cells | T-lymphoblastic leukemia | Homo sapiens | CVCL_0624 |
| MOLT4 cells | Adult T acute lymphoblastic leukemia | Homo sapiens | CVCL_0013 | |
| CEM/C1 cells | T acute lymphoblastic leukemia | Homo sapiens | CVCL_3496 | |
| Jurkat cells | T acute lymphoblastic leukemia | Homo sapiens | CVCL_0065 | |
| Response regulation | PAQR3 inhibited proliferation and aggravated ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability. This study suggested that PAQR3 may serve as an effective biological marker for ALL treatment. | |||
Myeloid leukaemia [ICD-11: 2B33]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | Progestin and adipoQ receptor family member 3 (PAQR3) | Protein coding | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Ubiquitin mediated proteolysis | hsa04120 | |||
| Cell Process | Cell ferroptosis | |||
| Cell proliferation | ||||
In Vitro Model |
MOLT-3 cells | T-lymphoblastic leukemia | Homo sapiens | CVCL_0624 |
| MOLT4 cells | Adult T acute lymphoblastic leukemia | Homo sapiens | CVCL_0013 | |
| CEM/C1 cells | T acute lymphoblastic leukemia | Homo sapiens | CVCL_3496 | |
| Jurkat cells | T acute lymphoblastic leukemia | Homo sapiens | CVCL_0065 | |
| Response regulation | PAQR3 inhibited proliferation and aggravated ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability. This study suggested that PAQR3 may serve as an effective biological marker for ALL treatment. | |||
